Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + Download Section PDF Listen ++ For further information, see CMDT Part 18-17: Pelvic Inflammatory Disease (Salpingitis, Endometritis) + Key Features Download Section PDF Listen +++ +++ Essentials of Diagnosis ++ Lower abdominal pain with uterine, adnexal, or cervical motion tenderness Absence of a competing diagnosis +++ General Considerations ++ A polymicrobial infection of the upper genital tract associated with The sexually transmitted organisms Neisseria gonorrhoeae and Chlamydia trachomatis Endogenous organisms, including anaerobes, Haemophilus influenzae, enteric gram-negative rods, and streptococci Leading cause of infertility and ectopic pregnancy +++ Demographics ++ Most common in young, nulliparous, sexually active women with multiple partners The use of barrier methods of contraception may provide significant protection + Clinical Findings Download Section PDF Listen +++ +++ Symptoms and Signs ++ Symptoms may include Lower abdominal pain Abnormal uterine bleeding Abnormal vaginal discharge Fever typically indicates more severe disease, including pelvic abscess Right upper quadrant pain (Fitz-Hugh and Curtis syndrome) may indicate an associated perihepatitis Diagnosis is complicated by the fact that many women have mild symptoms, not readily recognized as PID, such as postcoital bleeding, urinary frequency, or low back pain +++ MINIMUM DIAGNOSTIC CRITERIA ++ Women with cervical motion, uterine, or adnexal tenderness meet diagnostic criteria for PID and should be treated with antibiotics unless there is a competing diagnosis such as ectopic pregnancy or appendicitis. The following criteria may be used to enhance the specificity of the diagnosis Oral temperature > 38.3°C Abnormal cervical or vaginal discharge with white cells on saline microscopy (> 1 leukocyte per epithelial cell) Elevated erythrocyte sedimentation rate Elevated C-reactive protein Laboratory documentation of cervical infection with N gonorrhoeae or C trachomatis Treatment should not be delayed while awaiting results +++ Differential Diagnosis ++ Ectopic pregnancy Appendicitis Septic abortion Hemorrhagic or ruptured ovarian cyst or tumor Ovarian torsion Tubo-ovarian abscess Degeneration of myoma Acute enteritis + Diagnosis Download Section PDF Listen +++ +++ Laboratory Tests ++ Abnormal cervical or vaginal discharge may show white blood cells on saline microscopy Endocervical culture for N gonorrhoeae and saline wet mount for C trachomatis Erythrocyte sedimentation rate and C-reactive protein may be elevated +++ Imaging Studies ++ Pelvic and vaginal ultrasound can differentiate ectopic pregnancy of over 6 weeks +++ Diagnostic Procedures ++ Laparoscopy Can diagnose PID It is imperative if the diagnosis is not certain or if the patient has not responded to antibiotic therapy after 48 hours The appendix should be visualized at laparoscopy to rule out appendicitis Cultures obtained at the time of laparoscopy are often helpful + Treatment Download Section PDF Listen +++ +++ Medications ++ Antibiotic treatment should not be delayed while awaiting culture results The sexual partner should be examined and treated appropriately +++ INPATIENT REGIMENS ++ Cefotetan 2 g intravenously every 12 hours or cefoxitin 2 g intravenously every 6 hours plus doxycycline 100 mg orally or intravenously every 12 hours Clindamycin 900 mg intravenously every 8 hours plus gentamycin, a loading dose 2 mg/kg intravenously or intramuscularly followed by a maintenance dose of 1.5 mg/kg every 8 hours (or as a single daily dose, 3–5 mg/kg) These regimens should be continued for a minimum of 24 hours after the patient shows significant clinical improvement Then, an oral regimen should be started to complete a total of 14 days of therapy with either doxycycline, 100 mg orally twice a day, or clindamycin, 450 mg orally four times a day If a tubo-ovarian abscess is present, clindamycin or metronidazole should be used with doxycycline to complete the 14-day treatment for better anaerobic coverage +++ OUTPATIENT REGIMENS ++ Single dose of cefoxitin, 2 g intramuscularly, with probenecid, 1 g orally, plus doxycycline 100 mg orally twice daily for 14 days; or ceftriaxone 250 mg intramuscularly plus doxycycline, 100 mg orally twice daily, for 14 days Adding metronidazole (500 mg orally twice daily for 14 days) to either of these regimens treats bacterial vaginosis that is frequently associated with PID +++ Surgery ++ Tubo-ovarian abscesses may require surgical excision or transcutaneous or transvaginal aspiration Unilateral adnexectomy is acceptable for unilateral abscess Hysterectomy and bilateral salpingo-oophorectomy may be necessary for overwhelming infection or in cases of chronic disease with intractable pelvic pain + Outcome Download Section PDF Listen +++ +++ Follow-Up ++ Inpatient therapy for tubo-ovarian abscess should be monitored by ultrasound +++ Complications ++ In spite of treatment, one-fourth of women with acute disease develop long-term sequelae, including Repeated episodes of infection Chronic pelvic pain Dyspareunia Ectopic pregnancy Infertility The risk of infertility increases with repeated episodes of salpingitis: it is estimated at 10% after the first episode, 25% after a second episode, and 50% after a third episode +++ Prognosis ++ Early treatment with effective antibiotics is essential to prevent long-term sequelae For tubo-ovarian abscess, unless rupture is suspected, high-dose antibiotic therapy in the hospital is effective in 70% of cases. In 30%, there is inadequate response in 48–72 hours, and surgical intervention is required +++ When to Admit ++ Admit for intravenous antibiotic therapy if Patient has a tubo-ovarian abscess Patient is pregnant Patient is unable to follow or tolerate an outpatient regimen Patient has not responded clinically to outpatient therapy within 72 hours Patient has severe illness, nausea and vomiting, or high fever Surgical emergencies, such as appendicitis, cannot be ruled out + References Download Section PDF Listen +++ + +Curry A et al. Pelvic inflammatory disease: diagnosis, management and prevention. Am Fam Physician. 2019 Sep 15;100(6)357–64. [PubMed: 31524362] + +Ross J et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018 Feb;29(2):108–14. [PubMed: 29198181]